| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.33e-06 | 268 | 60 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.49e-06 | 188 | 60 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 3.02e-05 | 120 | 60 | 5 | GO:0004222 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 4.16e-05 | 430 | 60 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 5.03e-05 | 323 | 60 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 6.38e-05 | 26 | 60 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 8.91e-05 | 29 | 60 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | integrin binding | 1.81e-04 | 175 | 60 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | heparin binding | 2.78e-04 | 192 | 60 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | structural molecule activity | THBS3 THBS4 COMP HMCN1 EPB41L4B LAMA5 LTBP1 AGRN PGM5 RPL18A | 2.95e-04 | 891 | 60 | 10 | GO:0005198 |
| GeneOntologyMolecularFunction | metallopeptidase activity | 3.35e-04 | 200 | 60 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.73e-04 | 749 | 60 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 4.05e-04 | 599 | 60 | 8 | GO:0050839 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 4.85e-04 | 51 | 60 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | peptidase activity | 7.22e-04 | 654 | 60 | 8 | GO:0008233 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.24e-03 | 156 | 60 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | cytokine binding | 1.27e-03 | 157 | 60 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.38e-03 | 73 | 60 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | BMP binding | 1.97e-03 | 22 | 60 | 2 | GO:0036122 | |
| GeneOntologyMolecularFunction | laminin binding | 4.68e-03 | 34 | 60 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | fibronectin binding | 5.82e-03 | 38 | 60 | 2 | GO:0001968 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.29e-05 | 377 | 60 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.32e-05 | 378 | 60 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.34e-05 | 379 | 60 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | MAPK15 HLA-A ADAMTS1 MARK1 DPYSL5 ADAMTS16 SEMA5A LRRC7 AGRN PLXNB3 ITPR1 | 2.82e-05 | 846 | 60 | 11 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | MAPK15 HLA-A ADAMTS1 MARK1 DPYSL5 ADAMTS16 SEMA5A LRRC7 AGRN PLXNB3 ITPR1 | 3.38e-05 | 863 | 60 | 11 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of synaptic activity | 4.97e-05 | 4 | 60 | 2 | GO:0060025 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 6.44e-05 | 612 | 60 | 9 | GO:0010975 | |
| GeneOntologyBiologicalProcess | neuron projection development | ABLIM1 THBS4 HLA-A PTPRM ADAMTS1 MARK1 DPYSL5 LAMA5 SEMA5A LRRC7 AGRN PLXNB3 ITPR1 | 6.62e-05 | 1285 | 60 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of melanocyte differentiation | 8.27e-05 | 5 | 60 | 2 | GO:0045636 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | IGSF8 THBS4 MAPK15 PTPRM ADAMTS1 EPB41L4B ADAMTS9 SPOCK3 LAMA5 SEMA5A ADAM8 AGRN PLXNB3 | 9.19e-05 | 1327 | 60 | 13 | GO:0040012 |
| GeneOntologyBiologicalProcess | positive regulation of pigment cell differentiation | 1.73e-04 | 7 | 60 | 2 | GO:0050942 | |
| GeneOntologyBiologicalProcess | regulation of melanocyte differentiation | 1.73e-04 | 7 | 60 | 2 | GO:0045634 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.77e-04 | 285 | 60 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.80e-04 | 286 | 60 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | THBS4 COMP HMCN1 HLA-A PTPRM HLA-DQB2 FGFRL1 LRRC7 ADAM8 MEGF11 PLXNB3 | 2.43e-04 | 1077 | 60 | 11 | GO:0098609 |
| GeneOntologyBiologicalProcess | neuron development | ABLIM1 THBS4 HLA-A PTPRM ADAMTS1 MARK1 DPYSL5 LAMA5 SEMA5A LRRC7 AGRN PLXNB3 ITPR1 | 2.43e-04 | 1463 | 60 | 13 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of cell motility | IGSF8 THBS4 MAPK15 PTPRM ADAMTS1 EPB41L4B ADAMTS9 SPOCK3 LAMA5 SEMA5A ADAM8 PLXNB3 | 2.69e-04 | 1280 | 60 | 12 | GO:2000145 |
| GeneOntologyBiologicalProcess | positive regulation of developmental pigmentation | 2.96e-04 | 9 | 60 | 2 | GO:0048087 | |
| GeneOntologyBiologicalProcess | regulation of pigment cell differentiation | 2.96e-04 | 9 | 60 | 2 | GO:0050932 | |
| GeneOntologyCellularComponent | extracellular matrix | THBS3 THBS4 CLC COMP HMCN1 ADAMTS1 ADAMTS9 SPOCK3 VASN ADAMTS16 LAMA5 ADAMTS20 LTBP1 AGRN ANGPTL5 | 4.45e-10 | 656 | 61 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THBS3 THBS4 CLC COMP HMCN1 ADAMTS1 ADAMTS9 SPOCK3 VASN ADAMTS16 LAMA5 ADAMTS20 LTBP1 AGRN ANGPTL5 | 4.64e-10 | 658 | 61 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | THBS3 THBS4 CLC COMP HMCN1 ADAMTS1 ADAMTS9 LAMA5 ADAMTS20 LTBP1 AGRN ANGPTL5 | 3.51e-08 | 530 | 61 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 2.86e-05 | 122 | 61 | 5 | GO:0005604 | |
| Domain | EGF | CNTNAP3B THBS3 THBS4 COMP HMCN1 VASN CNTNAP3 CNTNAP4 LAMA5 LTBP1 ADAM8 AGRN MEGF11 | 4.35e-13 | 235 | 60 | 13 | SM00181 |
| Domain | EGF-like_dom | CNTNAP3B THBS3 THBS4 COMP HMCN1 VASN CNTNAP3 CNTNAP4 LAMA5 LTBP1 ADAM8 AGRN MEGF11 | 9.10e-13 | 249 | 60 | 13 | IPR000742 |
| Domain | EGF_1 | CNTNAP3B THBS3 THBS4 COMP HMCN1 VASN CNTNAP3 CNTNAP4 LAMA5 LTBP1 ADAM8 AGRN MEGF11 | 1.23e-12 | 255 | 60 | 13 | PS00022 |
| Domain | EGF_2 | CNTNAP3B THBS3 THBS4 COMP HMCN1 VASN CNTNAP3 CNTNAP4 LAMA5 LTBP1 ADAM8 AGRN MEGF11 | 2.01e-12 | 265 | 60 | 13 | PS01186 |
| Domain | EGF_3 | CNTNAP3B THBS3 THBS4 COMP HMCN1 VASN CNTNAP3 CNTNAP4 LTBP1 ADAM8 AGRN MEGF11 | 9.76e-12 | 235 | 60 | 12 | PS50026 |
| Domain | EGF-like_CS | THBS3 THBS4 COMP HMCN1 VASN CNTNAP3 CNTNAP4 LAMA5 LTBP1 ADAM8 AGRN MEGF11 | 3.33e-11 | 261 | 60 | 12 | IPR013032 |
| Domain | Laminin_G | 6.51e-10 | 58 | 60 | 7 | IPR001791 | |
| Domain | - | 6.84e-10 | 95 | 60 | 8 | 2.60.120.200 | |
| Domain | ConA-like_dom | CNTNAP3B THBS3 THBS4 CLC COMP PTPRM CNTNAP3 CNTNAP4 LAMA5 AGRN | 1.81e-09 | 219 | 60 | 10 | IPR013320 |
| Domain | Thbs/COMP_coiled-coil | 3.15e-08 | 3 | 60 | 3 | IPR024665 | |
| Domain | COMP | 3.15e-08 | 3 | 60 | 3 | PF11598 | |
| Domain | TSP_1 | 5.01e-08 | 63 | 60 | 6 | PF00090 | |
| Domain | TSP1 | 6.06e-08 | 65 | 60 | 6 | SM00209 | |
| Domain | TSP1_rpt | 6.06e-08 | 65 | 60 | 6 | IPR000884 | |
| Domain | TSP1 | 6.06e-08 | 65 | 60 | 6 | PS50092 | |
| Domain | LAM_G_DOMAIN | 1.34e-07 | 38 | 60 | 5 | PS50025 | |
| Domain | Peptidase_M12B_N | 1.53e-07 | 39 | 60 | 5 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.53e-07 | 39 | 60 | 5 | PF01562 | |
| Domain | EGF | 1.54e-07 | 126 | 60 | 7 | PF00008 | |
| Domain | DISINTEGRIN_1 | 1.74e-07 | 40 | 60 | 5 | PS00427 | |
| Domain | Reprolysin | 1.74e-07 | 40 | 60 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 1.74e-07 | 40 | 60 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.74e-07 | 40 | 60 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 1.74e-07 | 40 | 60 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 1.98e-07 | 41 | 60 | 5 | IPR001762 | |
| Domain | LamG | 2.85e-07 | 44 | 60 | 5 | SM00282 | |
| Domain | TSP_3 | 3.14e-07 | 5 | 60 | 3 | PF02412 | |
| Domain | TSP3 | 3.14e-07 | 5 | 60 | 3 | PS51234 | |
| Domain | TSP_CTER | 3.14e-07 | 5 | 60 | 3 | PS51236 | |
| Domain | - | 3.14e-07 | 5 | 60 | 3 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 3.14e-07 | 5 | 60 | 3 | IPR008859 | |
| Domain | TSP_C | 3.14e-07 | 5 | 60 | 3 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 3.14e-07 | 5 | 60 | 3 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 3.14e-07 | 5 | 60 | 3 | IPR003367 | |
| Domain | TSP_type-3_rpt | 3.14e-07 | 5 | 60 | 3 | IPR028974 | |
| Domain | Growth_fac_rcpt_ | 6.60e-07 | 156 | 60 | 7 | IPR009030 | |
| Domain | ADAM_spacer1 | 8.14e-07 | 23 | 60 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 8.14e-07 | 23 | 60 | 4 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 9.74e-07 | 24 | 60 | 4 | IPR013273 | |
| Domain | EGF_CA | 2.58e-06 | 122 | 60 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.83e-06 | 124 | 60 | 6 | IPR001881 | |
| Domain | FIBRINOGEN_C_1 | 3.23e-06 | 32 | 60 | 4 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 3.23e-06 | 32 | 60 | 4 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 3.23e-06 | 32 | 60 | 4 | PS51406 | |
| Domain | MetalloPept_cat_dom | 6.13e-06 | 81 | 60 | 5 | IPR024079 | |
| Domain | - | 6.13e-06 | 81 | 60 | 5 | 3.40.390.10 | |
| Domain | Laminin_G_2 | 8.06e-06 | 40 | 60 | 4 | PF02210 | |
| Domain | EGF_CA | 8.24e-06 | 86 | 60 | 5 | PF07645 | |
| Domain | Pept_M12B_GON-ADAMTSs | 1.01e-05 | 2 | 60 | 2 | IPR012314 | |
| Domain | GON | 1.01e-05 | 2 | 60 | 2 | PF08685 | |
| Domain | GON | 1.01e-05 | 2 | 60 | 2 | PS51046 | |
| Domain | Galactose-bd-like | 1.27e-05 | 94 | 60 | 5 | IPR008979 | |
| Domain | EGF_Ca-bd_CS | 1.48e-05 | 97 | 60 | 5 | IPR018097 | |
| Domain | ZINC_PROTEASE | 1.56e-05 | 98 | 60 | 5 | PS00142 | |
| Domain | EGF_CA | 1.64e-05 | 99 | 60 | 5 | PS01187 | |
| Domain | FA58C | 4.02e-05 | 21 | 60 | 3 | SM00231 | |
| Domain | FA58C_3 | 4.02e-05 | 21 | 60 | 3 | PS50022 | |
| Domain | FA58C_1 | 4.02e-05 | 21 | 60 | 3 | PS01285 | |
| Domain | FA58C_2 | 4.02e-05 | 21 | 60 | 3 | PS01286 | |
| Domain | F5_F8_type_C | 6.08e-05 | 24 | 60 | 3 | PF00754 | |
| Domain | FA58C | 6.08e-05 | 24 | 60 | 3 | IPR000421 | |
| Domain | Ig-like_fold | IGSF8 HMCN1 HLA-A PTPRM VASN HLA-DQB2 FGFRL1 KIR2DS5 PLXNB3 FCMR | 7.62e-05 | 706 | 60 | 10 | IPR013783 |
| Domain | FBG | 1.09e-04 | 29 | 60 | 3 | SM00186 | |
| Domain | - | 1.20e-04 | 30 | 60 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.20e-04 | 30 | 60 | 3 | IPR014716 | |
| Domain | IG_LIKE | 1.66e-04 | 491 | 60 | 8 | PS50835 | |
| Domain | Laminin_EGF | 1.92e-04 | 35 | 60 | 3 | PF00053 | |
| Domain | EGF_Lam | 1.92e-04 | 35 | 60 | 3 | SM00180 | |
| Domain | Ig-like_dom | 1.96e-04 | 503 | 60 | 8 | IPR007110 | |
| Domain | Laminin_EGF | 2.45e-04 | 38 | 60 | 3 | IPR002049 | |
| Domain | - | 2.48e-04 | 663 | 60 | 9 | 2.60.40.10 | |
| Domain | ig | 3.59e-04 | 190 | 60 | 5 | PF00047 | |
| Domain | Immunoglobulin | 3.59e-04 | 190 | 60 | 5 | IPR013151 | |
| Domain | - | 1.74e-03 | 74 | 60 | 3 | 3.40.50.410 | |
| Domain | IG | 2.27e-03 | 421 | 60 | 6 | SM00409 | |
| Domain | Ig_sub | 2.27e-03 | 421 | 60 | 6 | IPR003599 | |
| Domain | VWFA | 2.33e-03 | 82 | 60 | 3 | PS50234 | |
| Domain | TSPN | 2.46e-03 | 23 | 60 | 2 | SM00210 | |
| Domain | VWA | 2.50e-03 | 84 | 60 | 3 | SM00327 | |
| Domain | cEGF | 3.14e-03 | 26 | 60 | 2 | IPR026823 | |
| Domain | cEGF | 3.14e-03 | 26 | 60 | 2 | PF12662 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.25e-07 | 39 | 44 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.25e-07 | 39 | 44 | 5 | MM15165 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.93e-07 | 300 | 44 | 9 | M610 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.11e-06 | 68 | 44 | 5 | M27303 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.46e-06 | 140 | 44 | 6 | M587 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.04e-06 | 143 | 44 | 6 | M27275 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 6.03e-06 | 84 | 44 | 5 | M7098 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.15e-05 | 109 | 44 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.35e-05 | 111 | 44 | 5 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.18e-04 | 250 | 44 | 6 | M27554 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.46e-04 | 86 | 44 | 4 | M2642 | |
| Pathway | KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS | 5.14e-04 | 11 | 44 | 2 | M17946 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 5.32e-04 | 51 | 44 | 3 | MM14967 | |
| Pathway | KEGG_AXON_GUIDANCE | 6.84e-04 | 129 | 44 | 4 | M5539 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 8.46e-04 | 14 | 44 | 2 | MM15047 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.03e-03 | 64 | 44 | 3 | M7923 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.20e-03 | 258 | 44 | 5 | MM14572 | |
| Pubmed | 4.14e-09 | 75 | 61 | 6 | 20637190 | ||
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 5.13e-09 | 3 | 61 | 3 | 33910854 | |
| Pubmed | 1.53e-08 | 16 | 61 | 4 | 30579834 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 30622267 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 18467703 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 22562232 | ||
| Pubmed | 8.76e-08 | 210 | 61 | 7 | 16537572 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 2.86e-07 | 8 | 61 | 3 | 24460873 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.12e-06 | 12 | 61 | 3 | 25770910 | |
| Pubmed | ABLIM1 MAPK15 SPOCK3 DPYSL5 PRSS55 ADAMTS20 FGFRL1 SEMA5A LRRC7 ITPR1 | 1.43e-06 | 814 | 61 | 10 | 23251661 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 31150793 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 19329067 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26807827 | ||
| Pubmed | SEMA5A-PLXNB3 Axis Promotes PDAC Liver Metastasis Outgrowth through Enhancing the Warburg Effect. | 3.03e-06 | 2 | 61 | 2 | 36741230 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12514189 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 30446843 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11137453 | ||
| Pubmed | COMP and TSP-4 interact specifically with the novel GXKGHR motif only found in fibrillar collagens. | 3.03e-06 | 2 | 61 | 2 | 30464261 | |
| Pubmed | 3.43e-06 | 17 | 61 | 3 | 26389685 | ||
| Pubmed | 3.43e-06 | 17 | 61 | 3 | 22183742 | ||
| Pubmed | 5.03e-06 | 64 | 61 | 4 | 22261194 | ||
| Pubmed | 5.73e-06 | 20 | 61 | 3 | 19922873 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 7.72e-06 | 22 | 61 | 3 | 26494785 | |
| Pubmed | Differential gene expression of ADAMTS-1, ADAMTS-9 and TIMP-3 in periodontitis. | 9.07e-06 | 3 | 61 | 2 | 36093887 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 24753090 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 37169079 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 23562508 | ||
| Pubmed | 1.15e-05 | 167 | 61 | 5 | 22159717 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 20696765 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 16507336 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 1.81e-05 | 4 | 61 | 2 | 6338048 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 19850054 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 21706053 | ||
| Pubmed | An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. | 1.81e-05 | 4 | 61 | 2 | 11565031 | |
| Pubmed | 2.02e-05 | 30 | 61 | 3 | 16454711 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 12093160 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 31600785 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 15218527 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 3.08e-05 | 101 | 61 | 4 | 20551380 | |
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 3.52e-05 | 36 | 61 | 3 | 25615642 | |
| Pubmed | Proteolytic cleavage of versican during cardiac cushion morphogenesis. | 4.52e-05 | 6 | 61 | 2 | 16691565 | |
| Pubmed | Extracellular matrix of secondary lymphoid organs impacts on B-cell fate and survival. | 4.52e-05 | 6 | 61 | 2 | 23847204 | |
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 15668394 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 4.52e-05 | 6 | 61 | 2 | 34143959 | |
| Pubmed | Stargazer: a new neurological mutant on chromosome 15 in the mouse with prolonged cortical seizures. | 4.52e-05 | 6 | 61 | 2 | 2289471 | |
| Pubmed | SPOCK3 VASN SLC22A15 SYPL2 PRSS55 FGFRL1 ANGPTL5 MEGF11 HEPH | 5.23e-05 | 985 | 61 | 9 | 12975309 | |
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 15907280 | ||
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 15599946 | ||
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 23354118 | ||
| Pubmed | 8.42e-05 | 8 | 61 | 2 | 21041365 | ||
| Pubmed | Histocompatibility gene mutation rates in the mouse: a 25-year review. | 8.42e-05 | 8 | 61 | 2 | 9382920 | |
| Pubmed | 8.42e-05 | 8 | 61 | 2 | 8500908 | ||
| Pubmed | 8.42e-05 | 8 | 61 | 2 | 7030925 | ||
| Pubmed | 8.42e-05 | 8 | 61 | 2 | 15153510 | ||
| Pubmed | H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. | 8.42e-05 | 8 | 61 | 2 | 6407984 | |
| Pubmed | The secreted metalloprotease ADAMTS20 is required for melanoblast survival. | 8.42e-05 | 8 | 61 | 2 | 18454205 | |
| Pubmed | Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice. | 8.42e-05 | 8 | 61 | 2 | 12766770 | |
| Pubmed | 8.42e-05 | 8 | 61 | 2 | 6415206 | ||
| Pubmed | 8.42e-05 | 8 | 61 | 2 | 29472249 | ||
| Pubmed | In vivo requirement for Atg5 in antigen presentation by dendritic cells. | 1.08e-04 | 9 | 61 | 2 | 20171125 | |
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 23095891 | ||
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 24129702 | ||
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 19180512 | ||
| Pubmed | Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. | 1.08e-04 | 9 | 61 | 2 | 17446933 | |
| Pubmed | 1.29e-04 | 146 | 61 | 4 | 27068509 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 37712758 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 30383447 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 6096010 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 38426910 | ||
| Pubmed | Gene organization and recombinational hotspots in the murine major histocompatibility complex. | 1.35e-04 | 10 | 61 | 2 | 3754180 | |
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 18684933 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 37715782 | ||
| Pubmed | A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. | 1.35e-04 | 10 | 61 | 2 | 12242444 | |
| Pubmed | The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. | 1.35e-04 | 10 | 61 | 2 | 12119351 | |
| Pubmed | CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice. | 1.35e-04 | 10 | 61 | 2 | 19808251 | |
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 37877672 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 23869841 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 37219526 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 15623520 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 37966111 | ||
| Pubmed | 1.55e-04 | 153 | 61 | 4 | 10718198 | ||
| Pubmed | 1.58e-04 | 1139 | 61 | 9 | 36417873 | ||
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 22379998 | ||
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 20466823 | ||
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 25857745 | ||
| Pubmed | Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. | 1.65e-04 | 11 | 61 | 2 | 16860760 | |
| Pubmed | Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. | 1.65e-04 | 11 | 61 | 2 | 29988124 | |
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 16365422 | ||
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 10377186 | ||
| Pubmed | 1.65e-04 | 11 | 61 | 2 | 33909046 | ||
| Pubmed | 1.92e-04 | 162 | 61 | 4 | 25826454 | ||
| Pubmed | Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin. | 1.97e-04 | 12 | 61 | 2 | 12150895 | |
| Pubmed | 1.97e-04 | 12 | 61 | 2 | 12134058 | ||
| Pubmed | 1.97e-04 | 12 | 61 | 2 | 16862160 | ||
| Pubmed | 1.97e-04 | 12 | 61 | 2 | 16750824 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | IGSF8 HLA-A ADAMTS1 PDHA1 VASN LAMA5 LTBP1 AGRN ITPR1 RPL18A | 2.01e-04 | 1451 | 61 | 10 | 30550785 |
| Pubmed | 2.33e-04 | 13 | 61 | 2 | 12682087 | ||
| Pubmed | Extensive polymorphism surrounding the murine Ia A beta chain gene. | 2.33e-04 | 13 | 61 | 2 | 6311906 | |
| Pubmed | 2.33e-04 | 13 | 61 | 2 | 32909945 | ||
| Pubmed | cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity. | 2.33e-04 | 13 | 61 | 2 | 32788723 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 8.61e-08 | 19 | 41 | 4 | 50 | |
| GeneFamily | C1-set domain containing | 4.08e-03 | 42 | 41 | 2 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 4.47e-03 | 44 | 41 | 2 | 588 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.77e-03 | 161 | 41 | 3 | 593 | |
| GeneFamily | LIM domain containing | 7.91e-03 | 59 | 41 | 2 | 1218 | |
| Coexpression | NABA_MATRISOME | INTS6L THBS3 THBS4 CLC COMP HMCN1 ADAMTS1 ADAMTS9 SPOCK3 ADAMTS16 LAMA5 ADAMTS20 ESM1 SEMA5A LTBP1 ADAM8 AGRN ANGPTL5 MEGF11 PLXNB3 | 8.08e-14 | 1026 | 61 | 20 | M5889 |
| Coexpression | NABA_MATRISOME | INTS6L THBS3 THBS4 COMP HMCN1 ADAMTS1 ADAMTS9 SPOCK3 ADAMTS16 LAMA5 ADAMTS20 ESM1 SEMA5A LTBP1 ADAM8 AGRN MEGF11 PLXNB3 | 8.02e-12 | 1008 | 61 | 18 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | 6.47e-10 | 270 | 61 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 7.73e-10 | 275 | 61 | 10 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.45e-08 | 191 | 61 | 8 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.78e-08 | 196 | 61 | 8 | M3008 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | 1.23e-06 | 604 | 61 | 10 | M45760 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | CLC ADAMTS1 ADAMTS9 ADAMTS16 ADAMTS20 SEMA5A ADAM8 ANGPTL5 MEGF11 PLXNB3 | 8.46e-06 | 751 | 61 | 10 | M5885 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 1.83e-05 | 355 | 61 | 7 | M45758 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS | 3.00e-05 | 26 | 61 | 3 | M47999 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_DN | 4.05e-05 | 82 | 61 | 4 | M42504 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 4.66e-05 | 30 | 61 | 3 | M47990 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 5.37e-05 | 286 | 61 | 6 | M45746 | |
| Coexpression | GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP | 1.01e-04 | 199 | 61 | 5 | M9424 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.11e-04 | 40 | 61 | 3 | M5887 | |
| Coexpression | FOROUTAN_TGFB_EMT_DN | 1.19e-04 | 108 | 61 | 4 | M42502 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPRASP1 MDN1 MARK1 SPOCK3 SLC22A15 CNTNAP4 LAMA5 LRRC7 SYBU CCDC17 | 2.18e-04 | 1106 | 61 | 10 | M39071 |
| Coexpression | NABA_ECM_REGULATORS | 2.33e-04 | 238 | 61 | 5 | M3468 | |
| Coexpression | GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP | 2.35e-04 | 129 | 61 | 4 | M464 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | INTS6L THBS4 ADAMTS1 ADAMTS9 MARK1 LAMA5 SEMA5A LRRC7 LTBP1 ACYP2 AGRN ITPR1 | 7.07e-06 | 905 | 60 | 12 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.67e-06 | 261 | 60 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | HMCN1 ADAMTS9 SPOCK3 CNTNAP3 CNTNAP4 BCAT1 SEMA5A LRRC7 LTBP1 PGM5 | 3.62e-05 | 734 | 60 | 10 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 3.73e-05 | 450 | 60 | 8 | GSM777063_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 4.34e-05 | 69 | 60 | 4 | ratio_MESO_vs_SC_500_K2 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | THBS3 THBS4 MAPK15 PTPRM ADAMTS9 ARFGAP3 VASN DPYSL5 CNTNAP3 FGFRL1 LTBP1 ACYP2 AGRN HEPH | 4.49e-05 | 1466 | 60 | 14 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.74e-05 | 163 | 60 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_k2_1000 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.40e-04 | 281 | 60 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.40e-04 | 281 | 60 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | THBS3 THBS4 MAPK15 ADAMTS9 VASN DPYSL5 CNTNAP3 LAMA5 ACYP2 AGRN HEPH | 1.86e-04 | 1075 | 60 | 11 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 2.31e-04 | 439 | 60 | 7 | GSM777059_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | 2.97e-04 | 772 | 60 | 9 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.05e-04 | 114 | 60 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_1000 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 7.11e-09 | 191 | 60 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.58e-08 | 159 | 60 | 6 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-07 | 177 | 60 | 6 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-07 | 177 | 60 | 6 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-07 | 186 | 60 | 6 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.10e-07 | 189 | 60 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-07 | 190 | 60 | 6 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.17e-07 | 190 | 60 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 193 | 60 | 6 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.77e-07 | 198 | 60 | 6 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.93e-07 | 200 | 60 | 6 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 137 | 60 | 5 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.13e-06 | 155 | 60 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.34e-06 | 158 | 60 | 5 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.07e-06 | 167 | 60 | 5 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.55e-06 | 172 | 60 | 5 | c6bc78fd63c9479a84ec0552b55c89750cad0fa5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.55e-06 | 172 | 60 | 5 | bfb87a281a9cf6ad45b310bf8104fc0ab382b549 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.65e-06 | 173 | 60 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-06 | 176 | 60 | 5 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.31e-06 | 179 | 60 | 5 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.31e-06 | 179 | 60 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-06 | 180 | 60 | 5 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-06 | 180 | 60 | 5 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.55e-06 | 181 | 60 | 5 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.55e-06 | 181 | 60 | 5 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 4.55e-06 | 181 | 60 | 5 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.68e-06 | 182 | 60 | 5 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.68e-06 | 182 | 60 | 5 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-06 | 182 | 60 | 5 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.68e-06 | 182 | 60 | 5 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.68e-06 | 182 | 60 | 5 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-06 | 183 | 60 | 5 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-06 | 183 | 60 | 5 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-06 | 183 | 60 | 5 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.93e-06 | 184 | 60 | 5 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.93e-06 | 184 | 60 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-06 | 185 | 60 | 5 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-06 | 185 | 60 | 5 | 9de1db2ce9e44956b1214daf6e1e161334679c88 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-06 | 185 | 60 | 5 | 18f5d9438c76e37988a7d17aa2a080af6bedbfc4 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.06e-06 | 185 | 60 | 5 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-06 | 186 | 60 | 5 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.20e-06 | 186 | 60 | 5 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-06 | 186 | 60 | 5 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.20e-06 | 186 | 60 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.33e-06 | 187 | 60 | 5 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.33e-06 | 187 | 60 | 5 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.33e-06 | 187 | 60 | 5 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 187 | 60 | 5 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.33e-06 | 187 | 60 | 5 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 5.33e-06 | 187 | 60 | 5 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.47e-06 | 188 | 60 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.47e-06 | 188 | 60 | 5 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.47e-06 | 188 | 60 | 5 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.47e-06 | 188 | 60 | 5 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.62e-06 | 189 | 60 | 5 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 5.62e-06 | 189 | 60 | 5 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.62e-06 | 189 | 60 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-06 | 190 | 60 | 5 | 050d6e0546954675b6adbfecb67854b1e09739d1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.76e-06 | 190 | 60 | 5 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-06 | 190 | 60 | 5 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-06 | 191 | 60 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.06e-06 | 192 | 60 | 5 | 291df12b4b5ff11fbaa43033692b8f4b5cdf65a1 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 6.06e-06 | 192 | 60 | 5 | 7d9e5772b6e531b50ed4e4d6304ef11235f27f37 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.06e-06 | 192 | 60 | 5 | 35ffe7aa9ffab85eac3326651e901c39d0119650 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.06e-06 | 192 | 60 | 5 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.06e-06 | 192 | 60 | 5 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | healthy_donor-Lymphocytic-B_cell-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 6.06e-06 | 192 | 60 | 5 | 975312f9d6cede4d4f5b737e481e5c73accc8c50 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.22e-06 | 193 | 60 | 5 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.22e-06 | 193 | 60 | 5 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-06 | 193 | 60 | 5 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 6.22e-06 | 193 | 60 | 5 | 21fec35587ffb5c0157e54a821ce3ffd3e24e536 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-06 | 193 | 60 | 5 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.22e-06 | 193 | 60 | 5 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.22e-06 | 193 | 60 | 5 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-06 | 193 | 60 | 5 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.22e-06 | 193 | 60 | 5 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.38e-06 | 194 | 60 | 5 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.38e-06 | 194 | 60 | 5 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.38e-06 | 194 | 60 | 5 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.54e-06 | 195 | 60 | 5 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.54e-06 | 195 | 60 | 5 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.54e-06 | 195 | 60 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | distal-Endothelial-Lymphatic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.54e-06 | 195 | 60 | 5 | f45c1349932ee7eb419cced8a4fdedae3610953f | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.70e-06 | 196 | 60 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 197 | 60 | 5 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.87e-06 | 197 | 60 | 5 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 197 | 60 | 5 | 3f078be0b0f5e16edfb6d517beb20ac6178767f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-06 | 197 | 60 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.04e-06 | 198 | 60 | 5 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.04e-06 | 198 | 60 | 5 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-06 | 198 | 60 | 5 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.04e-06 | 198 | 60 | 5 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.22e-06 | 199 | 60 | 5 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.22e-06 | 199 | 60 | 5 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.22e-06 | 199 | 60 | 5 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.39e-06 | 200 | 60 | 5 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.39e-06 | 200 | 60 | 5 | 74a3b9ec8faa1d187ad8b0d12f5c89bde2d7248e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.39e-06 | 200 | 60 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| Drug | chondroitin sulfate | THBS3 THBS4 COMP ADAMTS1 ADAMTS9 SPOCK3 ADAMTS16 LAMA5 SEMA5A LTBP1 PAPSS1 AGRN PLXNB3 | 5.69e-11 | 413 | 61 | 13 | CID000024766 |
| Drug | LMWH | KLK15 THBS3 THBS4 HLA-A ADAMTS1 SPOCK3 LAMA5 FGFRL1 AGRN ITPR1 | 9.68e-06 | 663 | 61 | 10 | CID000000772 |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.26e-05 | 192 | 61 | 6 | 5238_UP | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 4.22e-07 | 8 | 59 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | serum IgE measurement | 2.90e-04 | 64 | 59 | 3 | EFO_0004579 | |
| Disease | cerebellum cortex volume change measurement | 3.52e-04 | 14 | 59 | 2 | EFO_0021497 | |
| Disease | glycerate measurement | 4.06e-04 | 15 | 59 | 2 | EFO_0021029 | |
| Disease | neck circumference | 6.58e-04 | 19 | 59 | 2 | EFO_0011043 | |
| Disease | carpal tunnel syndrome | 7.63e-04 | 89 | 59 | 3 | EFO_0004143 | |
| Disease | C-peptide measurement | 8.85e-04 | 22 | 59 | 2 | EFO_0005187 | |
| Disease | obesity (implicated_via_orthology) | 9.12e-04 | 215 | 59 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | respiratory failure, COVID-19 | 1.54e-03 | 29 | 59 | 2 | EFO_0009686, MONDO_0100096 | |
| Disease | sensory perception of taste | 1.99e-03 | 33 | 59 | 2 | GO_0050909 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 2.24e-03 | 35 | 59 | 2 | EFO_0004458, EFO_0004611 | |
| Disease | COVID-19 symptoms measurement | 2.24e-03 | 35 | 59 | 2 | EFO_0600019 | |
| Disease | lymphoid leukemia | 2.64e-03 | 38 | 59 | 2 | EFO_0004289 | |
| Disease | late-onset Alzheimers disease | 2.79e-03 | 292 | 59 | 4 | EFO_1001870 | |
| Disease | FEV/FEC ratio | 2.96e-03 | 1228 | 59 | 8 | EFO_0004713 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.03e-03 | 144 | 59 | 3 | EFO_0004611, EFO_0020943 | |
| Disease | Liver carcinoma | 3.43e-03 | 507 | 59 | 5 | C2239176 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.53e-03 | 152 | 59 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.86e-03 | 157 | 59 | 3 | DOID:224 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRVQGVCFRMYTEDE | 16 | P14621 | |
| QVVACTRGGMSRLFG | 171 | Q96LX7 | |
| GERMEVTAVATQGGY | 86 | Q9BZ76 | |
| DSDRLGMGFGNCRSV | 301 | Q9NP61 | |
| EGNRVREMFGSGTAC | 321 | P54687 | |
| QRMYGTRCHGCGEFV | 151 | O14639 | |
| TMRGGRLGVFCFSQE | 716 | P49747 | |
| GVTYENDCVMGRSGA | 361 | O00468 | |
| GERMEVTAVATQGGY | 86 | Q9C0A0 | |
| GRIGMRIEVFGCAYR | 166 | Q9C0A0 | |
| ADTRVGNMYVRGLSG | 201 | Q9H221 | |
| VMCDMDYRGGGRTVI | 181 | Q86XS5 | |
| RFEAGRCIMAGSIGS | 356 | P78325 | |
| GGGQMTVREGCYRDL | 886 | Q8TE57 | |
| SCGGGERSRESYCMN | 981 | P59510 | |
| QVDSNGRTGLMVACY | 126 | Q7Z3H0 | |
| GDTALDMRGRCSAGQ | 1191 | Q92878 | |
| CSRTCGGGVQYTMRE | 571 | Q9UHI8 | |
| EVTGGRSYCVRTQRM | 201 | Q5JSJ4 | |
| DRQGCTMVVGSDGRY | 56 | Q15124 | |
| SLSGACGMDRRQNTY | 901 | A6BM72 | |
| EMGMGNVERCRGFSA | 4216 | Q9NU22 | |
| VGNCGTFTRGYRAMV | 2381 | Q14643 | |
| GQRSMDGYPEQFCVR | 1436 | Q96NW7 | |
| RSRVYQMILECGGSS | 336 | Q8TD08 | |
| RCSGNEVYHIRMGDS | 536 | Q5JUK3 | |
| MCYFTNGTERVRGVA | 46 | P05538 | |
| MEQARRLCYTAGGRG | 326 | Q9ULL4 | |
| TRARQDDAGMYICLG | 326 | Q8N441 | |
| GRLTNTMVCAGAEGR | 186 | Q9H2R5 | |
| SGYRMTQRGRCEDID | 986 | Q14766 | |
| VCFGRRVVMNSREYG | 56 | Q05315 | |
| GSRQATGDYMGVSLR | 2786 | O15230 | |
| AGRYSCVATNEAGEM | 2641 | Q96RW7 | |
| SIGRMTQDLAGTYRC | 86 | Q14953 | |
| CEASLGGQRYVMRQS | 281 | O43900 | |
| DGCTAFALMYEGRRV | 321 | O43252 | |
| GTRMRYVSCRDENGS | 1201 | Q9P2N4 | |
| DRYRMVVGGAQAGDA | 251 | Q969P0 | |
| IMYGCDVGSDGRFLR | 121 | P04439 | |
| GGSMARRNTYVCERT | 496 | Q9P0L2 | |
| RGETCYRTVSGMDGM | 61 | Q9NQ30 | |
| RNVGLGTCSMFSRVG | 431 | Q8IZD6 | |
| MHVVRGRDGCEYSLG | 276 | Q9H329 | |
| GERMEVTAVATQGGY | 86 | Q96NU0 | |
| SRGRVVYENGVFMCA | 441 | Q9BPU6 | |
| GKYRCMIRTEGGVGI | 256 | P28827 | |
| HGTGVRCRFMAGAEE | 656 | Q5JY77 | |
| YSGETGAMVRCNNEA | 56 | Q5VXT5 | |
| EIYCQAGSHREAGMR | 696 | Q9BQS7 | |
| RRYACRGGGTCQMDA | 121 | P55055 | |
| TTAGAVTQCYRDMGA | 101 | Q02543 | |
| DGCLRRMGYIQGDSA | 156 | Q9UPV7 | |
| GRQRIEMRYCSSDGT | 746 | Q13591 | |
| MRGGRLGVFCFSQEN | 916 | P35443 | |
| ICENNRYGMGTSVER | 221 | P08559 | |
| RSGRYMSCGENHGVR | 246 | Q9NX95 | |
| VYACGAGMNTDRGKT | 101 | O60667 | |
| SMRGGRLGVFCFSQE | 911 | P49746 | |
| CVDRYGNEVMGSRIN | 361 | Q9BQ16 | |
| FTGLYCESQMGQGTR | 436 | Q6EMK4 | |
| GRTRYSRITGGMEAE | 61 | Q6UWB4 |